Skip to main content

Advertisement

Fig. 1 | Thrombosis Journal

Fig. 1

From: The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor

Fig. 1

Correlation between rivaroxaban concentration and clotting time and ETP. a. Correlation between rivaroxaban concentration and thromboelastometry clotting time (CT) in whole blood. R = 0.68, p < 0.005, n = 50. b. Correlation between rivaroxaban concentration and endogenous thrombin potential (ETP) in platelet-poor plasma. R = −0.72, p < 0.005, n = 47

Back to article page